<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore, in vaccinated monkeys, seven days after infection, the Sinovac inactivated vaccine at 6 μg/dose induced high titers of IgG antibodies directed against the S, RBD and lower levels of anti-N protein antibodies, high titers of virus neutralizing antibodies with no detected antibody-dependent enhancement of disease (ADE) (
 <xref rid="B40" ref-type="bibr">40</xref>). In contrast, anti-S protein IgG and neutralizing antibodies were detected in the 6 Rhesus monkeys vaccinated with Chadox1 (
 <xref rid="T2" ref-type="table">Table 2</xref>) (
 <xref rid="B39" ref-type="bibr">39</xref>). Moreover, regarding the concern of the increased pro-inflammatory events and cytokine storm related to the severity of COVID-19, the Sinovac vaccine was safe and did not promote any alteration in the frequencies of CD3
 <sup>+</sup>, CD4
 <sup>+</sup>, or CD8 T cells nor of secretion of IFN-γ, TNF-α, IL-2, IL-4, IL-5, or IL-6 (
 <xref rid="T2" ref-type="table">Table 2</xref>) (
 <xref rid="B40" ref-type="bibr">40</xref>). In contrast, increased levels of IFN-γ, TNF-α, IL-6, and IL-10 were observed in monkeys vaccinated with the Chadox1 vaccine (
 <xref rid="B39" ref-type="bibr">39</xref>) (
 <xref rid="T2" ref-type="table">Table 2</xref>) in which the frequencies of cytokine secreting T lymphocytes was not studied (
 <xref rid="T2" ref-type="table">Table 2</xref>).
</p>
